Search

everythinglearnresearchcommunity

for

Search:↓

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Dutasteride reduces DHT more effectively than finasteride.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

The method effectively measures drug impact on DHT levels in prostate treatments.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

ATP helps prevent skin damage from vandetanib by reducing stress.

Compound 15a was effective in inhibiting 5α-reductase.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

SHH protein helps nerve regeneration in hypertensive rats.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

New compounds show promise as nonsteroidal treatments for hair loss.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

5-alpha-reductase inhibitors significantly affect the penile tissue of hypertensive rats.